Literature DB >> 15673724

Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.

Carolina Serena1, F Javier Pastor, Félix Gilgado, Emilio Mayayo, Josep Guarro.   

Abstract

Using a murine model of disseminated infection caused by Trichosporon asahii, we have evaluated the efficacies of amphotericin B (AMB; 1 mg/kg of body weight/day), fluconazole (FLC; 20 mg/kg/twice a day), and micafungin (MFG; 5 mg/kg/twice a day). We tested these drugs alone and in combination (MFG with AMB and MFG with FLC). MFG with AMB showed a synergistic effect and demonstrated a higher degree of efficacy in prolonging survival and reducing the kidney fungal burden than either agent alone. The combination MFG with FLC was able to reduce significantly the kidney fungal burden in comparison to that achieved with either drug administered alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673724      PMCID: PMC547367          DOI: 10.1128/AAC.49.2.497-502.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Uncommon opportunistic fungi: new nosocomial threats.

Authors:  A H Groll; T J Walsh
Journal:  Clin Microbiol Infect       Date:  2001       Impact factor: 8.067

Review 2.  Newer antifungal therapy for emerging fungal pathogens.

Authors:  William J Steinbach; John R Perfect
Journal:  Int J Infect Dis       Date:  2003-03       Impact factor: 3.623

3.  Efficacy of micafungin alone or in combination against systemic murine aspergillosis.

Authors:  Javier Capilla Luque; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

4.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.

Authors:  F Ikeda; Y Wakai; S Matsumoto; K Maki; E Watabe; S Tawara; T Goto; Y Watanabe; F Matsumoto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia.

Authors:  J R Ebright; M R Fairfax; J A Vazquez
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

7.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 8.  Trichosporon beigelii infection: experience in a regional burn center.

Authors:  M J Cawley; G R Braxton; L R Haith; K J Reilly; R E Guilday; M L Patton
Journal:  Burns       Date:  2000-08       Impact factor: 2.744

9.  Trichosporon species infection in bone marrow transplanted patients.

Authors:  M L Moretti-Branchini; K Fukushima; A Z Schreiber; K Nishimura; P M Papaiordanou; P Trabasso; R Tanaka; M Miyaji
Journal:  Diagn Microbiol Infect Dis       Date:  2001-03       Impact factor: 2.803

Review 10.  Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.

Authors:  S Fournier; W Pavageau; M Feuillhade; S Deplus; A-M Zagdanski; O Verola; H Dombret; J M Molina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-11-01       Impact factor: 3.267

View more
  15 in total

1.  Sternal wound infection by Trichosporon inkin following cardiac surgery.

Authors:  Frances Davies; Sarah Logan; Elizabeth Johnson; John L Klein
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Experimental pathogenicity of a clinical isolate of Trichosporon dermatis in a murine model.

Authors:  Ying-Ping Lin; Yan-Ping Yang; Wen-Ming Huang; Yong-Hua Chen; Shun-Fan Li; Yi-Ming Fan
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

3.  Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.

Authors:  Carolina Serena; Félix Gilgado; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.

Authors:  Carolina Serena; Marçal Mariné; Guillermo Quindós; Alfonso J Carrillo; J F Cano; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

5.  Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.

Authors:  Jon A Olson; Jill P Adler-Moore; P J Smith; Richard T Proffitt
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.

Authors:  Clara Yustes; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.

Authors:  Marçal Mariné; Vinicius Leite Pedro Bom; Patricia Alves de Castro; Lizziane Kretli Winkelstroter; Leandra Naira Ramalho; Neil Andrew Brown; Gustavo Henrique Goldman
Journal:  Virulence       Date:  2015-03-09       Impact factor: 5.882

8.  In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.

Authors:  Houmin Li; Jianjun Qiao; Zhe Wan; Jianzhong Zhang
Journal:  Mycopathologia       Date:  2010-12-14       Impact factor: 2.574

Review 9.  Current knowledge of Trichosporon spp. and Trichosporonosis.

Authors:  Arnaldo L Colombo; Ana Carolina B Padovan; Guilherme M Chaves
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

10.  In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.

Authors:  Carolina Serena; Belkys Fernández-Torres; F Javier Pastor; Luciana Trilles; Márcia Dos Santos Lazéra; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.